COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
COLL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 198 industry peers in the Pharmaceuticals industry. While COLL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on COLL.
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
In the past year COLL had a positive cash flow from operations.
COLL had positive earnings in 4 of the past 5 years.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
COLL has a Return On Assets of 4.16%. This is amongst the best in the industry. COLL outperforms 86.87% of its industry peers.
COLL has a Return On Equity of 30.23%. This is amongst the best in the industry. COLL outperforms 95.45% of its industry peers.
COLL's Return On Invested Capital of 9.85% is amongst the best of the industry. COLL outperforms 86.36% of its industry peers.
COLL had an Average Return On Invested Capital over the past 3 years of 11.08%. This is significantly below the industry average of 41.61%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.16% | ||
| ROE | 30.23% | ||
| ROIC | 9.85% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
With an excellent Profit Margin value of 10.96%, COLL belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Profit Margin of COLL has declined.
With an excellent Operating Margin value of 26.91%, COLL belongs to the best of the industry, outperforming 91.41% of the companies in the same industry.
COLL's Operating Margin has improved in the last couple of years.
COLL has a better Gross Margin (59.76%) than 67.17% of its industry peers.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.91% | ||
| PM (TTM) | 10.96% | ||
| GM | 59.76% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
COLL has less shares outstanding than it did 1 year ago.
COLL has less shares outstanding than it did 5 years ago.
COLL has a better debt/assets ratio than last year.
2.2 Solvency
COLL has an Altman-Z score of 0.92. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
COLL's Altman-Z score of 0.92 is fine compared to the rest of the industry. COLL outperforms 61.11% of its industry peers.
The Debt to FCF ratio of COLL is 4.19, which is a neutral value as it means it would take COLL, 4.19 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.19, COLL belongs to the best of the industry, outperforming 85.86% of the companies in the same industry.
COLL has a Debt/Equity ratio of 3.44. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.44, COLL is not doing good in the industry: 80.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.44 | ||
| Debt/FCF | 4.19 | ||
| Altman-Z | 0.92 |
ROIC/WACC1.05
WACC9.34%
2.3 Liquidity
A Current Ratio of 0.95 indicates that COLL may have some problems paying its short term obligations.
COLL has a Current ratio of 0.95. This is amonst the worse of the industry: COLL underperforms 84.34% of its industry peers.
A Quick Ratio of 0.88 indicates that COLL may have some problems paying its short term obligations.
COLL has a Quick ratio of 0.88. This is in the lower half of the industry: COLL underperforms 79.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 446.61%, which is quite impressive.
The Earnings Per Share has been growing by 154.78% on average over the past years. This is a very strong growth
Looking at the last year, COLL shows a quite strong growth in Revenue. The Revenue has grown by 11.42% in the last year.
COLL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.31% yearly.
EPS 1Y (TTM)446.61%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%115.85%
Revenue 1Y (TTM)11.42%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%21.51%
3.2 Future
COLL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.42% yearly.
Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 1.92% on average per year.
EPS Next Y9.23%
EPS Next 2Y7.39%
EPS Next 3Y0.19%
EPS Next 5Y-5.42%
Revenue Next Year18.02%
Revenue Next 2Y10.75%
Revenue Next 3Y4.58%
Revenue Next 5Y1.92%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 4.28, which indicates a rather cheap valuation of COLL.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 95.96% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.98. COLL is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 3.92 indicates a rather cheap valuation of COLL.
COLL's Price/Forward Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 96.97% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COLL to the average of the S&P500 Index (21.38), we can say COLL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.28 | ||
| Fwd PE | 3.92 |
4.2 Price Multiples
COLL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. COLL is cheaper than 95.96% of the companies in the same industry.
98.48% of the companies in the same industry are more expensive than COLL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.36 | ||
| EV/EBITDA | 4.31 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y7.39%
EPS Next 3Y0.19%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.6
+0.73 (+2.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners117.57%
Inst Owner Change-0.07%
Ins Owners1.67%
Ins Owner Change4.27%
Market Cap886.79M
Analysts81.82
Price Target43.66 (58.19%)
Short Float %14.14%
Short Ratio10.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.98%
Min EPS beat(2)-0.88%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)17.6%
Min EPS beat(4)-0.88%
Max EPS beat(4)51.47%
EPS beat(8)6
Avg EPS beat(8)-18.82%
EPS beat(12)7
Avg EPS beat(12)-17.92%
EPS beat(16)7
Avg EPS beat(16)-30.58%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-3.25%
Max Revenue beat(4)0.39%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.39%
Revenue beat(16)6
Avg Revenue beat(16)-4.99%
PT rev (1m)0%
PT rev (3m)1.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.79%
EPS NY rev (1m)0%
EPS NY rev (3m)5.01%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-4.17%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)-0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.28 | ||
| Fwd PE | 3.92 | ||
| P/S | 1.4 | ||
| P/FCF | 4.36 | ||
| P/OCF | 4.33 | ||
| P/B | 3.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.31 |
EPS(TTM)6.45
EY23.37%
EPS(NY)7.05
Fwd EY25.53%
FCF(TTM)6.33
FCFY22.93%
OCF(TTM)6.38
OCFY23.11%
SpS19.65
BVpS7.12
TBVpS-25.67
PEG (NY)0.46
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.16% | ||
| ROE | 30.23% | ||
| ROCE | 14.72% | ||
| ROIC | 9.85% | ||
| ROICexc | 11.46% | ||
| ROICexgc | N/A | ||
| OM | 26.91% | ||
| PM (TTM) | 10.96% | ||
| GM | 59.76% | ||
| FCFM | 32.2% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score5
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.44 | ||
| Debt/FCF | 4.19 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 0.98% | ||
| Cap/Sales | 0.26% | ||
| Interest Coverage | 2.72 | ||
| Cash Conversion | 60.46% | ||
| Profit Quality | 293.87% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 0.92 |
F-Score5
WACC9.34%
ROIC/WACC1.05
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)446.61%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%115.85%
EPS Next Y9.23%
EPS Next 2Y7.39%
EPS Next 3Y0.19%
EPS Next 5Y-5.42%
Revenue 1Y (TTM)11.42%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%21.51%
Revenue Next Year18.02%
Revenue Next 2Y10.75%
Revenue Next 3Y4.58%
Revenue Next 5Y1.92%
EBIT growth 1Y-3.13%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year149.77%
EBIT Next 3Y32.76%
EBIT Next 5Y15.46%
FCF growth 1Y-25.87%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y-25.39%
OCF growth 3Y25.54%
OCF growth 5Y49.12%